PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.07
ESG score 80-90% of SAVA's 67.58. Walter Schloss would scrutinize governance quality and regulatory exposure.
54.47
Environmental score 80-90% of SAVA's 66.37. Walter Schloss would scrutinize carbon exposure and transition planning.
61.36
Social score 90-95% of SAVA's 64.79. Bill Ackman would demand clear social improvement catalysts.
61.37
Governance score 80-90% of SAVA's 71.59. Walter Schloss would scrutinize management accountability and board independence.